Angiotensin II receptor blocker (ARB)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Angiotensin II receptor blocker (ARB), covering 2009-02-18 to 2012-08-22. Get the full timeline:
Most recent: Clinical Trial Update: The Effect of Angiotensin II Type 1 Receptor Antagonists on the Size and Expansion Rate of Abdominal Aortas in Hypertensive Patients